Peter Classi

888 total citations
32 papers, 624 citations indexed

About

Peter Classi is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Psychiatry and Mental health. According to data from OpenAlex, Peter Classi has authored 32 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 11 papers in Cardiology and Cardiovascular Medicine and 7 papers in Psychiatry and Mental health. Recurrent topics in Peter Classi's work include Pulmonary Hypertension Research and Treatments (18 papers), Treatment of Major Depression (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). Peter Classi is often cited by papers focused on Pulmonary Hypertension Research and Treatments (18 papers), Treatment of Major Depression (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). Peter Classi collaborates with scholars based in United States, United Kingdom and Armenia. Peter Classi's co-authors include Christopher Sexton, Heather L. Gelhorn, Jill A. Bell, Susan Ball, J. Craig Nelson, Michael E. Thase, Joseph A. Johnston, Maurizio Fava, JonDavid Sparks and Sanjay Dubé and has published in prestigious journals such as Circulation, CHEST Journal and European Heart Journal.

In The Last Decade

Peter Classi

28 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Classi United States	12	242	118	103	97	92	32	624
Paul D. Nussbaum United States	12	196 0.8×	32 0.3×	28 0.3×	135 1.4×	89 1.0×	28	532
Richard W. Elwood United States	11	241 1.0×	52 0.4×	18 0.2×	177 1.8×	153 1.7×	19	644
Philippe Desmarais Canada	13	131 0.5×	41 0.3×	20 0.2×	68 0.7×	78 0.8×	34	634
Miguel Garcia‐Argibay Sweden	14	303 1.3×	23 0.2×	23 0.2×	238 2.5×	108 1.2×	48	619
Nicholas H. Neufeld Canada	13	190 0.8×	32 0.3×	13 0.1×	273 2.8×	141 1.5×	29	775
Robert W. Keefover United States	10	180 0.7×	66 0.6×	15 0.1×	180 1.9×	66 0.7×	17	476
Miguel Arce Rentería United States	17	347 1.4×	29 0.2×	20 0.2×	109 1.1×	49 0.5×	51	672
George M. Hoganson United States	7	356 1.5×	20 0.2×	14 0.1×	85 0.9×	53 0.6×	10	685
Miguel Catalá Spain	11	422 1.7×	99 0.8×	9 0.1×	177 1.8×	144 1.6×	15	700
Raul Silva United States	10	230 1.0×	48 0.4×	10 0.1×	63 0.6×	173 1.9×	23	452

Countries citing papers authored by Peter Classi

Since Specialization

Citations

This map shows the geographic impact of Peter Classi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Classi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Classi more than expected).

Fields of papers citing papers by Peter Classi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Classi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Classi. The network helps show where Peter Classi may publish in the future.

Co-authorship network of co-authors of Peter Classi

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Classi. A scholar is included among the top collaborators of Peter Classi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Classi. Peter Classi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heresi, Gustavo A., Bonnie B. Dean, Henry Lee, et al.. (2024). Burden of illness in patients with pulmonary hypertension due to interstitial lung disease: a real-world analysis. BMC Pulmonary Medicine. 24(1). 335–335. 2 indexed citations

Klinger, James R., et al.. (2023). Burden of pulmonary hypertension due to chronic obstructive pulmonary disease: Analysis of exacerbations and healthcare resource utilization in the United States. Respiratory Medicine. 219. 107412–107412. 5 indexed citations

Heresi, Gustavo A., Bonnie B. Dean, Peter Classi, et al.. (2022). Identifying Patients with Group 3 Pulmonary Hypertension Associated with COPD or ILD Using an Administrative Claims Database. Lung. 200(2). 187–203. 1 indexed citations

Yarlas, Aaron, Stephen C. Mathai, Steven D. Nathan, et al.. (2022). Considerations When Selecting Patient-Reported Outcome Measures for Assessment of Health-Related Quality of Life in Patients With Pulmonary Hypertension. CHEST Journal. 162(5). 1163–1175. 9 indexed citations

Highland, Kristin B., Rebecca Crawford, Peter Classi, et al.. (2021). Development of the Pulmonary Hypertension Functional Classification Self-Report: a patient version adapted from the World Health Organization Functional Classification measure. Health and Quality of Life Outcomes. 19(1). 202–202. 11 indexed citations

Tillotson, Glenn, Thomas P. Lodise, Peter Classi, Donna Mildvan, & James A. McKinnell. (2020). Antibiotic Treatment Failure and Associated Outcomes Among Adult Patients With Community-Acquired Pneumonia in the Outpatient Setting: A Real-world US Insurance Claims Database Study. Open Forum Infectious Diseases. 7(3). ofaa065–ofaa065. 14 indexed citations

Dean, Bonnie B., et al.. (2020). Medication Adherence and Healthcare Costs Among Patients with Pulmonary Arterial Hypertension Treated with Oral Prostacyclins: A Retrospective Cohort Study. Drugs - Real World Outcomes. 7(3). 229–239. 13 indexed citations

El‐Kersh, Karim, Christopher S. King, Eric Shen, Peter Classi, & Vijay Balasubramanian. (2020). CONTEMPORARY DOSING CHARACTERISTICS OF ORAL TREPROSTINIL IN REAL-WORLD CLINICAL PRACTICE IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION. CHEST Journal. 158(4). A2183–A2184. 1 indexed citations

Feldman, Jeremy, et al.. (2020). Abstract 15745: Health Outcomes in Pulmonary Arterial Hypertension Patients With COVID-19: A Real-world Analysis. Circulation. 142(Suppl_3). 2 indexed citations

10.

Mathai, Stephen C., Anna R. Hemnes, Scott Manaker, et al.. (2019). Identifying Patients with Pulmonary Arterial Hypertension Using Administrative Claims Algorithms. Annals of the American Thoracic Society. 16(7). 797–806. 28 indexed citations

11.

Mordin, Margaret, et al.. (2019). The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension. Lung. 198(1). 65–86. 10 indexed citations

12.

Howden, Reuben, et al.. (2018). Treatment with Prostacyclins Delays and Reduces Hospital Readmissions Among Pah Patients. Value in Health. 21. S262–S262.

13.

Ball, Susan, Peter Classi, & Ellen B. Dennehy. (2014). What happens next?: a claims database study of second-line pharmacotherapy in patients with major depressive disorder (MDD) who initiate selective serotonin reuptake inhibitor (SSRI) treatment. Annals of General Psychiatry. 13(1). 8–8. 10 indexed citations

14.

Classi, Peter, Denái R. Milton, Sarah A. Ward, Khaled Sarsour, & Joseph A. Johnston. (2012). Social and emotional difficulties in children with ADHD and the impact on school attendance and healthcare utilization. Child and Adolescent Psychiatry and Mental Health. 6(1). 33–33. 70 indexed citations

15.

Zimovetz, Evelina A., Sorrel Wolowacz, Peter Classi, & Julie Birt. (2012). Methodologies used in cost-effectiveness models for evaluating treatments in major depressive disorder: a systematic review. Cost Effectiveness and Resource Allocation. 10(1). 1–1. 37 indexed citations

16.

Classi, Peter, et al.. (2011). Patient characteristics, comorbidities, and medication use for children with ADHD with and without a co-occurring reading disorder: A retrospective cohort study. Child and Adolescent Psychiatry and Mental Health. 5(1). 38–38. 4 indexed citations

17.

Classi, Peter, et al.. (2011). Preferences related to attention-deficit/hyperactivity disorder and its treatment. Patient Preference and Adherence. 5. 33–33. 17 indexed citations

18.

Gelhorn, Heather L., Christopher Sexton, & Peter Classi. (2011). Patient Preferences for Treatment of Major Depressive Disorder and the Impact on Health Outcomes. The Primary Care Companion For CNS Disorders. 13(5). 46 indexed citations

19.

Meyers, Juliana, Peter Classi, Linda Wietecha, & Sean D. Candrilli. (2010). Economic burden and comorbidities of attention-deficit/hyperactivity disorder among pediatric patients hospitalized in the United States. Child and Adolescent Psychiatry and Mental Health. 4(1). 31–31. 22 indexed citations

20.

Chapman, Richard H., et al.. (2009). The cost and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs*. International Journal of Clinical Practice. 64(2). 169–181. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact